Literature DB >> 29689518

Characterizing anxiety subtypes and the relationship to behavioral phenotyping in major depression: Results from the EMBARC study.

Joseph M Trombello1, Diego A Pizzagalli2, Myrna M Weissman3, Bruce D Grannemann1, Crystal M Cooper1, Tracy L Greer1, Ashley L Malchow1, Manish K Jha1, Thomas J Carmody1, Benji T Kurian1, Christian A Webb2, Daniel G Dillon2, Patrick J McGrath3, Gerard Bruder3, Maurizio Fava4, Ramin V Parsey5, Melvin G McInnis6, Phil Adams7, Madhukar H Trivedi8.   

Abstract

The current study aimed to characterize the multifaceted nature of anxiety in patients with major depression by evaluating distinct anxiety factors. We then related these derived anxiety factors to performance on a Flanker Task of cognitive control, in order to further validate these factors. Data were collected from 195 patients with nonpsychotic chronic or recurrent major depression or dysthymic disorder. At baseline, participants completed self-report measures of anxiety, depression, and other related symptoms (mania, suicidality) and clinicians administered a structured diagnostic interview and the Hamilton Rating Scale for Depression, including anxiety/somatization items. Four discrete factors (State Anxiety, Panic, Neuroticism/Worry, and Restlessness/Agitation) emerged, with high degrees of internal consistency. Discriminant and convergent validity analyses also yielded findings in the expected direction. Furthermore, the neuroticism/worry factor was associated with Flanker Task interference, such that individuals higher on neuroticism/worry responded more incorrectly (yet faster) to incongruent vs. congruent trials whereas individuals higher on the fear/panic factor responded more slowly, with no accuracy effect, to the Flanker Task stimuli. These results parse anxiety into four distinct factors that encompass physiological, psychological, and cognitive components of anxiety. While state anxiety, panic and neuroticism/worry are related to existing measures of anxiety, the Restlessness/Agitation factor appears to be a unique measure of general anxious arousal. Furthermore, two factors were independently validated through the Flanker Task. These results suggest that these anxiety domains have distinct behavioral profiles and could have differential responses to distinct treatments.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anxiety; Depression; Factor analysis; Flanker Task

Mesh:

Substances:

Year:  2018        PMID: 29689518      PMCID: PMC6097520          DOI: 10.1016/j.jpsychires.2018.04.003

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  29 in total

1.  A RATIONALE AND TEST FOR THE NUMBER OF FACTORS IN FACTOR ANALYSIS.

Authors:  J L HORN
Journal:  Psychometrika       Date:  1965-06       Impact factor: 2.500

2.  Development and validation of a 30-item short adaptation of the Mood and Anxiety Symptoms Questionnaire (MASQ).

Authors:  Klaas J Wardenaar; Tineke van Veen; Erik J Giltay; Edwin de Beurs; Brenda W J H Penninx; Frans G Zitman
Journal:  Psychiatry Res       Date:  2010-05-15       Impact factor: 3.222

3.  Concise Health Risk Tracking scale: a brief self-report and clinician rating of suicidal risk.

Authors:  Madhukar H Trivedi; Stephen R Wisniewski; David W Morris; Maurizio Fava; Jackie K Gollan; Diane Warden; Andrew A Nierenberg; Bradley N Gaynes; Mustafa M Husain; James F Luther; Sidney Zisook; A John Rush
Journal:  J Clin Psychiatry       Date:  2011-06       Impact factor: 4.384

4.  A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale.

Authors:  R P Snaith; M Hamilton; S Morley; A Humayan; D Hargreaves; P Trigwell
Journal:  Br J Psychiatry       Date:  1995-07       Impact factor: 9.319

5.  Testing the Short and Screener versions of the Social Adjustment Scale-Self-report (SAS-SR).

Authors:  Marc J Gameroff; Priya Wickramaratne; Myrna M Weissman
Journal:  Int J Methods Psychiatr Res       Date:  2011-12-05       Impact factor: 4.035

6.  The Altman Self-Rating Mania Scale.

Authors:  E G Altman; D Hedeker; J L Peterson; J M Davis
Journal:  Biol Psychiatry       Date:  1997-11-15       Impact factor: 13.382

7.  Multicenter collaborative panic disorder severity scale.

Authors:  M K Shear; T A Brown; D H Barlow; R Money; D E Sholomskas; S W Woods; J M Gorman; L A Papp
Journal:  Am J Psychiatry       Date:  1997-11       Impact factor: 18.112

8.  Latent structure of social fears and social anxiety disorders.

Authors:  M Iza; M M Wall; R G Heimberg; T L Rodebaugh; F R Schneier; S-M Liu; C Blanco
Journal:  Psychol Med       Date:  2013-03-12       Impact factor: 7.723

Review 9.  Fear and anxiety: animal models and human cognitive psychophysiology.

Authors:  P J Lang; M Davis; A Ohman
Journal:  J Affect Disord       Date:  2000-12       Impact factor: 4.839

10.  Anger attacks in depressed outpatients and their response to fluoxetine.

Authors:  M Fava; J F Rosenbaum; M McCarthy; J Pava; R Steingard; E Bless
Journal:  Psychopharmacol Bull       Date:  1991
View more
  3 in total

1.  Psychometric Properties of the Concise Associated Symptom Tracking Scale and Validation of Clinical Utility in the EMBARC Study.

Authors:  Abu Minhajuddin; Manish K Jha; Cherise Chin Fatt; Madhukar H Trivedi
Journal:  Psychiatr Res Clin Pract       Date:  2020-09-09

2.  Specific Dimensions of Depression Have Different Associations With Cognitive Decline in Older Adults With Type 2 Diabetes.

Authors:  Laili Soleimani; Ramit Ravona-Springer; Hung-Mo Lin; Xiaoyu Liu; Mary Sano; Anthony Heymann; Michal Schnaider Beeri
Journal:  Diabetes Care       Date:  2021-01-19       Impact factor: 19.112

3.  Childhood trauma history is linked to abnormal brain connectivity in major depression.

Authors:  Meichen Yu; Kristin A Linn; Russell T Shinohara; Desmond J Oathes; Philip A Cook; Romain Duprat; Tyler M Moore; Maria A Oquendo; Mary L Phillips; Melvin McInnis; Maurizio Fava; Madhukar H Trivedi; Patrick McGrath; Ramin Parsey; Myrna M Weissman; Yvette I Sheline
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-08       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.